Frequently Asked Questions
The market is segmented based on , By Type (Combined First Trimester Screening, Second Trimester Maternal Serum Screening), Tested Conditions (Edwards Syndrome, Patau Syndrome, Down syndrome, Neural Tube Defects), End-User (Diagnostic Laboratories, Hospitals) – Industry Trends and Forecast to 2030.
.
The Global Maternal Blood Test Market size was valued at USD 3.81 USD Billion in 2022.
The Global Maternal Blood Test Market is projected to grow at a CAGR of 13% during the forecast period of 2023 to 2030.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
